SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-013043
Filing Date
2018-05-10
Accepted
2018-05-10 17:08:56
Documents
72
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 2018 Q1 10-Q mlnt-10q_20180331.htm 10-Q 1526603
2 EX-31.1 mlnt-ex311_8.htm EX-31.1 17295
3 EX-31.2 mlnt-ex312_7.htm EX-31.2 17254
4 EX-32.1 mlnt-ex321_6.htm EX-32.1 6404
5 EX-32.2 mlnt-ex322_9.htm EX-32.2 6335
  Complete submission text file 0001564590-18-013043.txt   8743788

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mlnt-20180331.xml EX-101.INS 2195794
7 XBRL TAXONOMY EXTENSION SCHEMA mlnt-20180331.xsd EX-101.SCH 66087
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mlnt-20180331_cal.xml EX-101.CAL 55129
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mlnt-20180331_def.xml EX-101.DEF 286161
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mlnt-20180331_lab.xml EX-101.LAB 533688
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mlnt-20180331_pre.xml EX-101.PRE 432017
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35405 | Film No.: 18823935
SIC: 2834 Pharmaceutical Preparations